Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
Background: Abacavir and lamivudine are approved for once-daily use in HIV-infected adults Limited pharmacokinetic (PK) data for abacavir and lamivudine in children are available. Methods: A crossover study to compare PK of once- versus twice-daily abacavir and lamivudine was conducted in virologica...
Saved in:
Main Authors: | Torsak Bunupuradah (Author), Passorn Punyahotra (Author), Tim R. Cressey (Author), Amornrat Srimuan (Author), Narukjaporn Thammajaruk (Author), Jiratchaya Sophonphan (Author), Chulalak Sriheara (Author), David M. Burger (Author), Thanyawee Puthanakit (Author), Jintanat Ananworanich (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abacavir/lamivudine combination in the treatment of HIV: a review
by: Geetha Sivasubramanian, et al.
Published: (2010) -
Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011) -
Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
by: Nadia Kancheva Landolt, et al.
Published: (2017) -
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks
by: Julián Olalla, et al.
Published: (2018) -
Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions
by: Ekawan Yoosakul, et al.
Published: (2016)